Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiqi Wenyang Jiedu prescription is a Traditional Chinese Medicine (TCM) herbal formula designed to supplement Qi, warm Yang, and detoxify the body. It is primarily investigated for its potential to prevent postoperative metastasis and recurrence in patients with gastric cancer. The formula typically comprises a combination of herbs such as *Astragalus membranaceus*, *Codonopsis pilosula*, and *Scutellaria barbata*, which are believed to modulate the immune system, inhibit tumor cell proliferation, and improve the microenvironment to suppress cancer progression. It is often used as an adjuvant therapy alongside standard surgical and chemotherapeutic treatments to improve patient outcomes and quality of life.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yiqi Wenyang Jiedu prescription.